Founded in 1926, we are one of Brazil’s largest and most respected healthcare organizations, known as a reference for the medical community and the general public due to our technical, medical, service, and management quality. By the end of 2023, we had over 22.400 employees and 4.900 physicians, and we uphold the best ESG practices, contributing to the sustainability of the healthcare system. Our brands play a key role in individuals’ healthcare journey:
We operate in four growth avenues, namely:
- Diagnostic Medicine: B2C with PSCs, mobile care service, B2B for hospitals and lab-to-lab for diagnostic laboratories across the country.
- New Links: Drug Infusion, Orthopedics, Ophthalmology, Ambulatory Surgery Center and Reproductive Medicine.
- Health Platform: B2C Marketplace with a services portfolio of medical teleconsultations, diagnostic medicine exams and low-complexity procedures.
Since 2017, 11 diagnostic medicine acquisitions have been completed, which added brands, new PSCs and new operating regions, including the business combination with the Pardini Group announced in June 2022. In New Links (i.e., New Businesses), six acquisitions were completed.
